Outcomes of CLL Patients After Treatment with BTK & BCL2 Inhibitors - EHA 2022 CLL Society 7:35 1 year ago 91 Далее Скачать
Outcomes of CLL patients following treatment with a covalent BTK and BCL2 inhibitor VJHemOnc – Video Journal of Hematology & HemOnc 1:19 2 years ago 102 Далее Скачать
Outcomes of patients with CLL discontinuing BTK inhibitors due to adverse effects VJHemOnc – Video Journal of Hematology & HemOnc 1:12 3 days ago 41 Далее Скачать
The real-world outcomes of patients with CLL who discontinue BTKi therapy VJHemOnc – Video Journal of Hematology & HemOnc 1:45 5 months ago 127 Далее Скачать
Outcomes for CLL Patients Treated with BTK inhibitor and BCL2 inhibitor - ASH 2021 CLL Society 4:21 1 year ago 85 Далее Скачать
Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:43 1 year ago 621 Далее Скачать
Novel options for patients with CLL who relapse after treatment with BTK inhibitors and venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 1:52 1 year ago 416 Далее Скачать
The impact of age and comorbidities on the outcomes of patients with CLL treated with BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 0:59 1 year ago 87 Далее Скачать
CLL-Frail trial: efficacy & safety of acalabrutinib in elderly (≥80y) and/or frail patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:33 1 day ago 20 Далее Скачать
BTK Inhibitor Treatment Side Effects | What CLL Patients Should Know Patient Empowerment Network 3:27 1 year ago 95 Далее Скачать
CLL outcomes after CD19 CAR-T with ibrutinib VJHemOnc – Video Journal of Hematology & HemOnc 3:50 4 years ago 256 Далее Скачать
Treating patients with CLL who progress after BTK inhibitor therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:22 3 years ago 419 Далее Скачать
Customizing CLL care with BTK Inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 2:37 2 years ago 83 Далее Скачать
Clinical outcomes are poor for CLL patients treated with venetoclax post-BTKi exposure VJHemOnc – Video Journal of Hematology & HemOnc 1:31 10 months ago 568 Далее Скачать
Chronic Lymphocytic Leukemia (CLL) Developments For Patients & Caregivers (Ft. Dr. Nicole Lamanna) The Patient Story 43:52 2 years ago 1 986 Далее Скачать
Outcomes of patients with CLL-associated autoimmune cytopenias treated with different therapies VJHemOnc – Video Journal of Hematology & HemOnc 1:21 1 year ago 129 Далее Скачать
Comparing BTK and BCL-2 inhibitor outcomes in different CLL subgroups VJHemOnc – Video Journal of Hematology & HemOnc 5:00 3 years ago 476 Далее Скачать
Treatment Options for CLL after Bruton’s Tyrosine Kinase Inhibitor and Venetoclax (BCL2i) - ASH 2021 CLL Society 12:40 1 year ago 150 Далее Скачать
Outcomes for CLL Patients After Treatment With Ibrutinib Plus Venetoclax - Dr. John Allan ASH 2022 CLL Society 12:05 1 year ago 207 Далее Скачать
